Quanterix Corp. reported the publication of a landmark study in Nature which utilized its Simoa p-Tau 217 (phosphorylated tau at threonine 217) research assay. The Nature study is the largest population-based assessment of Alzheimer’s Disease Neuropathological Changes to date, providing crucial, scalable data to redefine disease prevalence it said.